Encompass Health Co. (NYSE:EHC) Shares Acquired by Vestcor Inc

Vestcor Inc boosted its position in Encompass Health Co. (NYSE:EHC - Free Report) by 5.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 60,775 shares of the company's stock after acquiring an additional 2,896 shares during the quarter. Vestcor Inc owned 0.06% of Encompass Health worth $5,613,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of EHC. State Street Corp grew its stake in shares of Encompass Health by 0.7% during the third quarter. State Street Corp now owns 3,025,769 shares of the company's stock worth $292,410,000 after purchasing an additional 21,329 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Encompass Health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company's stock worth $161,781,000 after acquiring an additional 20,547 shares in the last quarter. Copeland Capital Management LLC increased its holdings in shares of Encompass Health by 0.7% in the 4th quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company's stock valued at $119,418,000 after acquiring an additional 8,548 shares during the last quarter. Point72 Asset Management L.P. raised its position in shares of Encompass Health by 2,458.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock worth $83,990,000 after acquiring an additional 835,135 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in Encompass Health during the fourth quarter worth approximately $77,944,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the stock. KeyCorp raised their price objective on shares of Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a report on Monday, February 10th. Barclays boosted their price target on shares of Encompass Health from $116.00 to $118.00 and gave the company an "overweight" rating in a research report on Friday, February 7th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $110.00 price objective on shares of Encompass Health in a report on Tuesday, February 11th. William Blair reissued an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Finally, StockNews.com raised Encompass Health from a "hold" rating to a "buy" rating in a research report on Saturday, February 15th. Ten research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus target price of $107.67.

Encompass Health Stock Performance

NYSE:EHC traded down $0.22 during mid-day trading on Tuesday, reaching $97.53. The stock had a trading volume of 560,635 shares, compared to its average volume of 633,628. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The business has a 50 day simple moving average of $97.48 and a 200 day simple moving average of $97.01. Encompass Health Co. has a twelve month low of $74.45 and a twelve month high of $104.55. The firm has a market capitalization of $9.82 billion, a price-to-earnings ratio of 21.87, a PEG ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, beating analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. On average, analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be issued a $0.17 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.70%. Encompass Health's dividend payout ratio is presently 15.25%.

Insider Activity at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares of the company's stock, valued at approximately $6,798,129.56. The trade was a 6.79 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 2.10% of the company's stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.